Physical Activity Versus Pulmonary Rehabilitation in COPD

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial

— LIVELY  

Official title:

PhysicaL actIvity interVention vErsus puLmonarY Rehabilitation in COPD: The LIVELY COPD Project.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02161393
• Other study ID #: WT12/20
• Status: Completed
• Phase: N/A
• First received: May 28, 2013
• Last updated: August 24, 2017
• Start date: February 2014
• Est. completion date: January 19, 2016

Study information

• Verified date: August 2017
• Source: University of Ulster
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary aim of this study is to assess the feasibility of conducting a trial to investigate the effectiveness of a physical activity intervention (physical activity consultation and a pedometer-based walking programme) versus pulmonary rehabilitation in improving physical activity in COPD.

Objectives are:

(i) to assess the feasibility (patient recruitment, adherence, drop-outs and adverse events) of delivering a physical activity intervention in the COPD patient population versus pulmonary rehabilitation; (ii) to explore users perceptions relating to satisfaction and benefits of a physical activity intervention versus pulmonary rehabilitation; (iii) to investigate between and within group change in physical activity, exercise capacity, quality of life, self-efficacy and changes in the transtheoretical model with the physical activity intervention versus pulmonary rehabilitation; and (iv) to examine the cost of delivering a physical activity intervention versus pulmonary rehabilitation for patients with COPD.

The hypothesis for this study is that it will be feasible to conduct a trial that will investigate the effectiveness of a physical activity intervention (physical activity consultation and a pedometer-based walking programme) compared to pulmonary rehabilitation for improving physical activity in COPD. The study will provide important information about interventions designed to promote and maintain physical activity, improve patient outcomes and increase patients' choice relating to exercise and physical activity interventions. It will provide a rationale and data for an adequately powered clinical trial evaluating the effects of a physical activity intervention.

Description:

A survey of pulmonary rehabilitation programmes mirrored the results of other UK studies and highlighted that there are not enough programmes available; currently in the UK less than 1.5% of patients with COPD receive pulmonary rehabilitation per year. Only a proportion of patients are targeted i.e. those with moderate to severe disease. The majority of programmes are outpatient-based and are supervised by clinicians. This structured and supervised format of pulmonary rehabilitation does not meet the needs of all patients with high numbers of dropouts and non-adherence; yet alternative options for increasing physical activity for patients with COPD currently do not seem to be offered.

A home-based pedometer-driven walking intervention offers an alternative method of delivering physical activity training that could be provided to larger numbers of patients, at a lower cost and with flexibility around life commitments. It would also provide patients with more choice when deciding whether to participate in exercise or physical activity.

To date no study has compared a home-based walking intervention to structured, supervised pulmonary rehabilitation or the patient preferences or cost of the two programmes. For this reason, there is a need to compare a home-based-walking intervention to the standard method of providing patients with physical activity training, i.e. pulmonary rehabilitation. Therefore this study is essential as it will assess the feasibility of conducting a trial to investigate the efficacy of a physical activity intervention (physical activity consultation and a pedometer-based walking programme) versus pulmonary rehabilitation in improving physical activity in COPD.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: January 19, 2016
• Est. primary completion date: January 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. The Patient must be referred to pulmonary rehabilitation.

2. The Patient must have a Primary diagnosis of COPD

3. The Patient must have a good understanding of written English (as reported by the individual patient)

4. The Patient must be in a stable phase (not on antibiotics at the time of assessment with the ISWT), and deemed clinically stable by the clinical pulmonary rehabilitation team.

Exclusion Criteria:

1. The inability to safely take part in a walking programme or pulmonary rehabilitation (e.g. unstable angina, neurological, spinal or skeletal dysfunction affecting ability to exercise)

2. The inability to comprehend or follow instructions (e.g. dementia).

3. Clinically unstable (Pulmonary exacerbation or any change in symptoms and medication in the last 4 weeks)

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Behavioral:
• Physical Activity Intervention
The 12 week home-based pedometer-driven walking programme will consist of weekly physical activity consultations. Pedometers will be used to set weekly step goals and motivate patients. Patients will wear the pedometer for 7 days and will record their daily steps in a step diary. At the next appointment the step target for the subsequent week will be agreed between the physiotherapist/researcher and participant. Each week thereafter the physiotherapist/researcher and patient will discuss their progress, document their mean daily step count for the previous week, and agree to a new daily step target for the subsequent week. The walking programme will be tailored to the individual and progressed on a weekly basis.
• Pulmonary Rehabilitation Programme
This will be a 6-week supervised outpatient programme. The exercise component will last for one hour and be delivered twice weekly. It will consist of cardiovascular exercises and lower and upper body strengthening exercises. Education sessions will be delivered once weekly. Each patient will be provided with a home exercise programme to complete unsupervised once weekly.

Locations

Country	Name	City	State
United Kingdom	Belfast Health and Social Care Trust	Belfast	Co Antrim
United Kingdom	Western Health and Social Care Trust	Enniskillen

Sponsors (5)

Lead Sponsor	Collaborator
University of Ulster	Belfast Health and Social Care Trust, Katholieke Universiteit Leuven, Queen's University, Belfast, Western Health and Social Care Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline in physical activity will be assessed using step counts recorded with an Actigraph activity monitor.	The activity monitor is worn for 7 consecutive full days prior to the intervention, and 7 full days immediately after the intervention.	Baseline and at 6-weeks for PR group and 12-weeks for PA group
Secondary	Change from baseline in time spent in physical activity and in sitting using the International Physical Activity Questionnaire		Baseline and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation
Secondary	Change from baseline in exercise Capacity using the Incremental Shuttle Walk Test		Baseline, and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation
Secondary	Change from baseline in Quality of Life using the EuroQOL-5D		Baseline, and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation
Secondary	Change from baseline in Quality of Life using the COPD Assessment Test		Baseline, and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation
Secondary	Stage of change in terms of physical activity using the Stages of Change Questionnaire	The Stages of Change Questionnaire is the temporal part of the transtheoretical model. It will be used to determine the current stage of change the participant is at in terms of their physical activity behaviour.	Baseline, and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation
Secondary	Confidence to undertake physical activity using Marcus's Self-Efficacy Questionnaire	Marcus's Self-Efficacy Questionnaire is a component of the transtheoretical model which will provide more detailed information on each individual's confidence to undertake physical activity in different situations.	Baseline and at 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation
Secondary	Patients' perceptions of both interventions will be obtained via semi-structured interviews.	Information will be collected with regards patient satisfaction with their exercise/activity, information regarding ease of execution, safety and tolerability of the programmes and the outcome measures, views about continuing exercise and suggestions for improving the programmes.	At 6-weeks for PR group and 12-weeks for PA group
Secondary	Feasibility of the interventions	For both interventions information will be collected on recruitment and retention, dropouts, adherence and adverse events which will be necessary to establish feasibility.	End of study
Secondary	Global Rating of Change Questionnaire	This is a numerical rating scale about their patient's perception of any change in their physical activity	At 6-weeks for PR group and 12-weeks for PA group, and follow up at 18 (PR group) and 24 (PA group) weeks post randomisation
Secondary	Physical activity will be assessed using step counts recorded with an Actigraph activity monitor.		At 18 (PR group) and 24 (PA group) weeks post randomisation